Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease
Clinical trial NCT03225846 · TERMINATED
Trial details
- NCT number
- NCT03225846
- Sponsor
- Wave Life Sciences USA, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-17
- Primary completion
- 2021-05-10
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.